fluorobenzenes has been researched along with Injuries, Spinal Cord in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cleveland, KH; Schnellmann, RG; Scholpa, NE; Simmons, EC | 1 |
| Caliskan, A; Demirtas, S; Guclu, O; Karahan, O; Mavitas, B; Yavuz, C; Yazici, S | 1 |
| Aksoy, N; Cemil, DB; Erdoğan, B; Gökçe, A; Gökçe, EC; Gürer, B; Kahveci, FO; Kahveci, R; Kisa, U; Sargon, MF | 1 |
| Ji, Q; Li, W; Li, Y; Liu, J; Shu, Y; Zhang, L; Zhu, S | 1 |
| Cho, SI; Gwag, BJ; Lee, HY; Lim, HR; Moon, GJ; Noh, JS; Park, EJ; Rao, RR; Springer, JE | 1 |
| Arslan, S; Güler, A; Kılıçkaya, O; Onan, B; Oztaş, E; Sahin, MA; Ucak, A; Uysal, B; Yılmaz, AT | 1 |
6 other study(ies) available for fluorobenzenes and Injuries, Spinal Cord
| Article | Year |
|---|---|
5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury.
Topics: Animals; Carbazoles; Cross-Sectional Studies; Female; Fluorobenzenes; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Organelle Biogenesis; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Recovery of Function; Serotonin Receptor Agonists; Spinal Cord; Spinal Cord Injuries; Time Factors | 2020 |
Rosuvastatin may have neuroprotective effect on spinal cord ischemia reperfusion injury.
Topics: Animals; Antioxidants; Biomarkers; Fluorobenzenes; Male; Nerve Degeneration; Neuroprotective Agents; Pyrimidines; Rats; Reactive Oxygen Species; Reperfusion Injury; Rosuvastatin Calcium; Spinal Cord; Spinal Cord Injuries; Sulfonamides | 2013 |
Neuroprotective effects of rosuvastatin against traumatic spinal cord injury in rats.
Topics: Animals; Fluorobenzenes; Male; Neuroprotective Agents; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Spinal Cord Injuries; Sulfonamides; Thoracic Vertebrae; Treatment Outcome | 2014 |
Rosuvastatin attenuated the existing morphine tolerance in rats with L5 spinal nerve transection through inhibiting activation of astrocytes and phosphorylation of ERK42/44.
Topics: Analgesics, Opioid; Animals; Astrocytes; Drug Interactions; Drug Tolerance; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fluorobenzenes; Glial Fibrillary Acidic Protein; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1beta; Male; Morphine; Neuralgia; Phosphorylation; Pyrimidines; Rats, Sprague-Dawley; Rosuvastatin Calcium; Spinal Cord Injuries; Spinal Nerves; Sulfonamides; Tumor Necrosis Factor-alpha | 2015 |
The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury.
Topics: Acute Disease; Animals; Antioxidants; Benzoates; Disease Models, Animal; Drug Administration Schedule; Female; Fluorobenzenes; Free Radicals; meta-Aminobenzoates; Mitochondria; Motor Activity; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Rats; Rats, Long-Evans; Recovery of Function; Salicylates; Spinal Cord; Spinal Cord Injuries; Treatment Outcome | 2010 |
Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats.
Topics: Analysis of Variance; Animals; Aorta, Abdominal; Cytoprotection; Disease Models, Animal; Fluorobenzenes; Glutathione Peroxidase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Malondialdehyde; Motor Activity; Necrosis; Neurologic Examination; Neuroprotective Agents; Pyrimidines; Rats; Rats, Wistar; Reperfusion Injury; Rosuvastatin Calcium; Spinal Cord; Spinal Cord Injuries; Sulfonamides; Superoxide Dismutase; Time Factors | 2011 |